Who
David Jin
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Fortress Biotech; Director, Mustang Bio; Interim PFO and COO, Avenue Therapeutics.
In numbers
- Trades disclosed
- 18
- Buys
- 4
- Sells
- 0
- Bought
- $37K
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 1
- First trade
- 26 Oct 2022
- Last trade
- 1 Oct 2026
- Last filed
- 1 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Oct 2026filed 1 Oct 2026 | FBIO Fortress BiotechBiotechnology | SEC FORM 4 Code A | $2,1651,190 at $1.82 | filing |
| 22 Jun 2026filed 24 Jun 2026 | FBIO Fortress BiotechBiotechnology | SEC FORM 4 Code A | —400,000 at $0.00 | filing |
| 22 Jun 2026filed 24 Jun 2026 | FBIO Fortress BiotechBiotechnology | SEC FORM 4 Code A | —400,000 at $0.00 | filing |
| 1 Apr 2026filed 1 Apr 2026 | FBIO Fortress BiotechBiotechnology | SEC FORM 4 Code A | $6,4562,967 at $2.18 | filing |
| 1 Apr 2026filed 1 Apr 2026 | FBIO Fortress BiotechBiotechnology | SEC FORM 4 Code A | $6,4682,967 at $2.18 | filing |
| 30 Dec 2025filed 30 Dec 2025 | MBIO Mustang BioBiotechnology | SEC FORM 4 Bought | $237247 at $0.96 | filing |
| 1 Oct 2025filed 2 Oct 2025 | FBIO Fortress BiotechBiotechnology | SEC FORM 4 Code A | $3,5512,711 at $1.31 | filing |
| 1 Apr 2025filed 1 Apr 2025 | FBIO Fortress BiotechBiotechnology | SEC FORM 4 Code A | $6,1005,000 at $1.22 | filing |
| 19 Dec 2024filed 23 Dec 2024 | FBIO Fortress BiotechBiotechnology | SEC FORM 4 Code A | —1,000,000 at $0.00 | filing |
| 1 Oct 2024filed 1 Oct 2024 | FBIO Fortress BiotechBiotechnology | SEC FORM 4 Code A | $3,2292,625 at $1.23 | filing |
| 23 Sep 2024filed 25 Sep 2024 | Avenue TherapeuticsBiotechnology | SEC FORM 4 Code A | —65,000 at $0.00 | filing |
| 10 Jul 2024filed 12 Jul 2024 | FBIO Fortress BiotechBiotechnology | SEC FORM 4 Bought | $3,750500 at $7.50 | filing |
| 1 Apr 2024filed 2 Apr 2024 | FBIO Fortress BiotechBiotechnology | SEC FORM 4 Code A | $3,9982,352 at $1.70 | filing |
| 20 Dec 2023filed 22 Dec 2023 | FBIO Fortress BiotechBiotechnology | SEC FORM 4 Code A | —140,000 at $0.00 | filing |
| 30 Jun 2023filed 5 Jul 2023 | Avenue Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
| 10 Feb 2023filed 14 Feb 2023 | FBIO Fortress BiotechBiotechnology | SEC FORM 4 Bought | $30K35,928 at $0.84 | filing |
| 30 Nov 2022filed 2 Dec 2022 | FBIO Fortress BiotechBiotechnology | SEC FORM 4 Bought | $2,8005,000 at $0.56 | filing |
| 26 Oct 2022filed 28 Oct 2022 | FBIO Fortress BiotechBiotechnology | SEC FORM 4 Code A | —1,350,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.